Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 25556540)

Published in Liver Int on January 23, 2015

Authors

Philippe Sultanik1,2, Vincent Mallet1,2, Sylvie Lagaye2, Armanda Casrouge3, Céline Dorival4, Yoann Barthe4, Hélène Fontaine1,2, Christophe Hézode5, Estelle Mottez6, Jean-Pierre Bronowicki7, Fabrice Carrat4,8, Ioannis Theodorou9, Laurent Abel10,11,12, Etienne Gayat13,14, Arnaud Fontanet15, Stanislas Pol1,2, Matthew L Albert3,6, ANRS CO20-CUPIC

Author Affiliations

1: Department of Hepatology, Hôpital Cochin, AP-HP, Paris, France.
2: INSERM U 1016, CNRS UMR 8104, Université Paris Descartes UMR-S 1016, Paris, France.
3: The laboratory of Dendritic Cell Biology, Departement of Immunology, Institut Pasteur, INSERM U818, Paris, France.
4: UMR-S 707, Université Pierre et Marie Curie-Paris 6 & INSERM, Paris, France.
5: Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, AP-HP, Université Paris-Est, Créteil, France.
6: Centre for Human Immunology, Departement of Immunology, Institut Pasteur, INSERM S20, Paris, France.
7: Centre Hospitalier Universitaire de Nancy, Université de Lorraine, INSERM U954, Vandoeuvre-les-Nancy, France.
8: Department of Public Health, Hôpital Saint-Antoine, AP-HP, Paris, France.
9: Laboratory of Immunity and Infection, Groupe Hospitalier Pitié-Salpêtrière AP-HP, INSERM UMR-S 945, UPMC Université Paris 6, Paris, France.
10: Laboratory of Human Genetics of Infectious Diseases, Necker branch, INSERM U1163, Paris, France.
11: University Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France.
12: Laboratory of Human Genetics of Infectious Diseases, Rockefeller branch, The Rockefeller University, New-York, USA.
13: Department of Anesthesiology and Critical Care Medicine - Mobile Care Unit, Hôpital Lariboisière, AP-HP, Paris, France.
14: Biomarkers and cardiac diseases, Hôpital Lariboisière, INSERM U942, Paris, France.
15: Departement of Epidemiology of Infectious Disease, Institut Pasteur, Paris, France.

Associated clinical trials:

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin (CUPIC) | NCT01514890